Literature DB >> 20521842

Crystal structure of the human Hsmar1-derived transposase domain in the DNA repair enzyme Metnase.

Kristie D Goodwin1, Hongzhen He, Tsuyoshi Imasaki, Suk-Hee Lee, Millie M Georgiadis.   

Abstract

Although the human genome is littered with sequences derived from the Hsmar1 transposon, the only intact Hsmar1 transposase gene exists within a chimeric SET-transposase fusion protein referred to as Metnase or SETMAR. Metnase retains many of the transposase activities including terminal inverted repeat (TIR) specific DNA-binding activity, DNA cleavage activity, albeit uncoupled from TIR-specific binding, and the ability to form a synaptic complex. However, Metnase has evolved as a DNA repair protein that is specifically involved in nonhomologous end joining. Here, we present two crystal structures of the transposase catalytic domain of Metnase revealing a dimeric enzyme with unusual active site plasticity that may be involved in modulating metal binding. We show through characterization of a dimerization mutant, F460K, that the dimeric form of the enzyme is required for its DNA cleavage, DNA-binding, and nonhomologous end joining activities. Of significance is the conservation of F460 along with residues that we propose may be involved in the modulation of metal binding in both the predicted ancestral Hsmar1 transposase sequence as well as in the modern enzyme. The Metnase transposase has been remarkably conserved through evolution; however, there is a clustering of substitutions located in alpha helices 4 and 5 within the putative DNA-binding site, consistent with loss of transposition specific DNA cleavage activity and acquisition of DNA repair specific cleavage activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20521842     DOI: 10.1021/bi100171x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Biochemical characterization of metnase's endonuclease activity and its role in NHEJ repair.

Authors:  Brian D Beck; Sung-Sook Lee; Elizabeth Williamson; Robert A Hromas; Suk-Hee Lee
Journal:  Biochemistry       Date:  2011-04-27       Impact factor: 3.162

2.  Crystallization of and selenomethionine phasing strategy for a SETMAR-DNA complex.

Authors:  Qiujia Chen; Millie Georgiadis
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-08-26       Impact factor: 1.056

3.  Chk1 phosphorylation of Metnase enhances DNA repair but inhibits replication fork restart.

Authors:  R Hromas; E A Williamson; S Fnu; Y-J Lee; S-J Park; B D Beck; J-S You; A Leitao; A Laitao; J A Nickoloff; S-H Lee
Journal:  Oncogene       Date:  2012-01-09       Impact factor: 9.867

Review 4.  Moving DNA around: DNA transposition and retroviral integration.

Authors:  Sherwin P Montaño; Phoebe A Rice
Journal:  Curr Opin Struct Biol       Date:  2011-03-24       Impact factor: 6.809

5.  Retroviral integrase: Structure, mechanism, and inhibition.

Authors:  Dario Oliveira Passos; Min Li; Robert Craigie; Dmitry Lyumkis
Journal:  Enzymes       Date:  2021-08-23

6.  Targeting the transposase domain of the DNA repair component Metnase to enhance chemotherapy.

Authors:  Elizabeth A Williamson; Leah Damiani; Andrei Leitao; Chelin Hu; Helen Hathaway; Tudor Oprea; Larry Sklar; Montaser Shaheen; Julie Bauman; Wei Wang; Jac A Nickoloff; Suk-Hee Lee; Robert Hromas
Journal:  Cancer Res       Date:  2012-10-22       Impact factor: 12.701

Review 7.  Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives.

Authors:  Federico Andreoli; Arménio Jorge Moura Barbosa; Marco Daniele Parenti; Alberto Del Rio
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.310

8.  The SET Domain Is Essential for Metnase Functions in Replication Restart and the 5' End of SS-Overhang Cleavage.

Authors:  Hyun-Suk Kim; Sung-Kyung Kim; Robert Hromas; Suk-Hee Lee
Journal:  PLoS One       Date:  2015-10-05       Impact factor: 3.240

9.  Structural basis of Mos1 transposase inhibition by the anti-retroviral drug Raltegravir.

Authors:  Urszula M Wolkowicz; Elizabeth R Morris; Michael Robson; Maryia Trubitsyna; Julia M Richardson
Journal:  ACS Chem Biol       Date:  2014-01-10       Impact factor: 5.100

10.  The DDN catalytic motif is required for Metnase functions in non-homologous end joining (NHEJ) repair and replication restart.

Authors:  Hyun-Suk Kim; Qiujia Chen; Sung-Kyung Kim; Jac A Nickoloff; Robert Hromas; Millie M Georgiadis; Suk-Hee Lee
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.